1. Home
  2. RLJ vs NTLA Comparison

RLJ vs NTLA Comparison

Compare RLJ & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ

RLJ Lodging Trust of Beneficial Interest $0.01 par value

HOLD

Current Price

$8.17

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$13.82

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLJ
NTLA
Founded
2011
2014
Country
United States
United States
Employees
73
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
RLJ
NTLA
Price
$8.17
$13.82
Analyst Decision
Hold
Buy
Analyst Count
6
20
Target Price
$8.58
$20.45
AVG Volume (30 Days)
1.8M
3.9M
Earning Date
01-01-0001
05-21-2026
Dividend Yield
7.37%
N/A
EPS Growth
N/A
27.43
EPS
N/A
N/A
Revenue
N/A
$67,671,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.36
$73.07
P/E Ratio
$188.67
N/A
Revenue Growth
N/A
16.92
52 Week Low
$6.16
$5.90
52 Week High
$9.58
$28.24

Technical Indicators

Market Signals
Indicator
RLJ
NTLA
Relative Strength Index (RSI) 54.45 54.60
Support Level $6.93 $10.44
Resistance Level $8.56 $14.61
Average True Range (ATR) 0.31 0.96
MACD -0.02 0.09
Stochastic Oscillator 44.77 58.72

Price Performance

Historical Comparison
RLJ
NTLA

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: